Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Proposals for the use of live attenuated human immunodeficiency virus (HIV) type 1 (HIV-1) as a vaccine candidate in humans have been based on the protection afforded by attenuated simian immunodeficiency virus in the macaque model. Although it is not yet known if this strategy could succeed in humans, a study of the Sydney Blood Bank Cohort (SBBC), infected with an attenuated HIV-1 quasispecies with natural nef and nef/long terminal repeat deletions for up to 17 years, could provide insights into the long-term immunological consequences of living with an attenuated HIV-1 infection. In this study, HIV-specific cytoxic T-lymphocyte (CTL) responses in an SBBC donor and six recipients were examined over a 3-year period with enzyme-linked immunospot, tetrameric complex binding, direct CTL lysis, and CTL precursor level techniques. Strong HIV-specific CTL responses were detected in four of seven patients, including one patient with an undetectable viral load. Two of seven patients had weak CTL responses, and in one recipient, no HIV-specific CTLs were detected. High levels of circulating effector and memory HIV-specific CTLs can be maintained for prolonged periods in these patients despite very low viral loads.

Original publication

DOI

10.1128/jvi.73.1.436-443.1999

Type

Journal article

Journal

Journal of virology

Publication Date

01/1999

Volume

73

Pages

436 - 443

Addresses

Australian Red Cross Blood Service-NSW, Sydney, New South Wales, Australia. wdyer@arcbs.redcross.org.au

Keywords

T-Lymphocytes, Cytotoxic, Humans, HIV-1, Viremia, Acquired Immunodeficiency Syndrome, Gene Products, nef, HLA-A2 Antigen, Blood Donors, Female, Male, Simian immunodeficiency virus, nef Gene Products, Human Immunodeficiency Virus